Amdocs Limited Files Q2 2024 6-K Report
Ticker: DOX · Form: 6-K · Filed: May 20, 2024 · CIK: 1062579
| Field | Detail |
|---|---|
| Company | Amdocs LTD (DOX) |
| Form Type | 6-K |
| Filed Date | May 20, 2024 |
| Risk Level | low |
| Pages | 13 |
| Reading Time | 16 min |
| Key Dollar Amounts | $359, $277, $2,466, $2,160, $0.479 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-report, quarterly-filing, sec-filing
Related Tickers: DOX
TL;DR
Amdocs (DOX) filed its Q2 2024 6-K, check the numbers for the latest performance.
AI Summary
Amdocs Limited filed a Form 6-K for the quarter ended March 31, 2024, reporting its financial results. The company is incorporated in Guernsey and has its principal executive offices in St. Louis, Missouri. Amdocs Limited is subject to reporting requirements under the 1934 Act and files annual reports under Form 20-F.
Why It Matters
This filing provides an update on Amdocs Limited's financial performance and regulatory compliance for the second quarter of 2024, which is crucial for investors to assess the company's current standing.
Risk Assessment
Risk Level: low — This is a routine financial filing (6-K) that does not contain new material information or significant events.
Key Players & Entities
- Amdocs Limited (company) — Registrant
- March 31, 2024 (date) — Quarter End Date
- 20240520 (date) — Filing Date
- Form 6-K (document) — Filing Type
- Form 20-F (document) — Annual Report Form
FAQ
What is the filing date of this Form 6-K?
The filing date of this Form 6-K is May 20, 2024.
For which period is Amdocs Limited reporting?
Amdocs Limited is reporting for the quarter ended March 31, 2024.
What is the Commission File Number for Amdocs Limited?
The Commission File Number for Amdocs Limited is 1-14840.
Does Amdocs Limited file its annual reports under Form 20-F or Form 40-F?
Amdocs Limited files its annual reports under cover of Form 20-F.
Where are Amdocs Limited's principal executive offices located?
Amdocs Limited's principal executive offices are located at 625 Maryville Centre Drive, Suite 200, Saint Louis, Missouri 63141.
Filing Stats: 4,041 words · 16 min read · ~13 pages · Grade level 19.5 · Accepted 2024-05-20 16:08:04
Key Financial Figures
- $359 — 2,349 $ 298,012 (1) Net of tax of $359 and $277 for the three months ended Mar
- $277 — 298,012 (1) Net of tax of $359 and $277 for the three months ended March 31, 20
- $2,466 — 31, 2024 and 2023, respectively, and of $2,466 and $2,160 for the six months ended Mar
- $2,160 — d 2023, respectively, and of $2,466 and $2,160 for the six months ended March 31, 2024
- $0.479 — (115,416 ) Cash dividends declared ($0.479 per ordinary share) — ȁ
- $0.435 — (105,616 ) Cash dividends declared ($0.435 per ordinary share) — ȁ
- $5,495 — n (loss) on derivatives, net of tax, of $5,495 and $(33,383) unrealized loss on short-
- $0.914 — (273,941 ) Cash dividends declared ($0.914 per ordinary share) — ȁ
- $0.830 — (205,637 ) Cash dividends declared ($0.830 per ordinary share) — ȁ
- $255 — he six months ended March 31, 2024, and $255 for the six months ended March 31, 2023
- $84,500 — gate net consideration of approximately $84,500 in cash, and a potential for additional
- $86,894 — alues for Astadia, the Company recorded $86,894 of goodwill, $27,677 of customer relati
- $27,677 — e Company recorded $86,894 of goodwill, $27,677 of customer relationships to be amortiz
- $8,001 — amortized over approximately six years, $8,001 of core technology to be amortized over
- $1,784 — ized over approximately four years, and $1,784 of trademark to be amortized over appro
Filing Documents
- 6k_q2_24.htm (6-K) — 1948KB
- 0000950170-24-062388.txt ( ) — 1949KB
FINANCIAL INFORMATION
PART I FINANCIAL INFORMATION 3
Financial Statements
Item 1. Financial Statements 3 Unaudited Consolidated Financial Statements Consolidated Balance Sheets 3 Consolidated Statements of Income 4 Consolidated Statements of Comprehensive Income 5 Consolidated Statements of Changes in Equity 6 Consolidated Statements of Cash Flows 8 Notes to Unaudited Consolidated Financial Statements 9
Operating and Financial Review and Prospects
Item 2. Operating and Financial Review and Prospects 22
OTHER INFORMATION
PART II OTHER INFORMATION 31
Changes in Securities, Use of Proceeds and Issuer Purchases of Equity Securities
Item 1. Changes in Securities, Use of Proceeds and Issuer Purchases of Equity Securities 31
Reports on Form 6-K
Item 2. Reports on Form 6-K 31
SIGNATURES
SIGNATURES 31 This report on Form 6-K shall be incorporated by reference into any Registration Statement filed by the Registrant that by its terms automatically incorporates the Registrant's filings and submissions with the SEC under Sections 13(a), 13(c) or 15(d) of the Securities Exchange Act of 1934. 2
FINAN CIAL INFORMATION
PART I FINAN CIAL INFORMATION
F inancial Statements
Item 1. F inancial Statements AMDOCS LIMITED CONSOLI DATED BALANCE SHEETS (dollar and share amounts in thousands, except per share data) As of March 31, 2024 September 30, 2023 (Unaudited) ASSETS Current assets: Cash and cash equivalents $ 342,915 $ 520,080 Short-term interest-bearing investments 201,441 222,451 Accounts receivable, net 1,039,440 944,477 Prepaid expenses and other current assets 223,180 224,622 Total current assets 1,806,976 1,911,630 Property and equipment, net 766,123 790,923 Lease assets 162,745 160,938 Goodwill 2,834,553 2,749,041 Intangible assets, net 189,301 181,539 Other noncurrent assets 644,946 631,582 Total assets $ 6,404,644 $ 6,425,653 LIABILITIES AND EQUITY Current liabilities: Accounts payable $ 312,022 $ 293,344 Accrued expenses and other current liabilities 740,181 634,742 Accrued personnel costs 150,314 214,695 Lease liabilities 39,514 39,960 Deferred revenue 127,441 170,634 Total current liabilities 1,369,472 1,353,375 Deferred income taxes and taxes payable 203,270 252,609 Lease liabilities 117,777 121,654 Long-term debt, net of unamortized debt issuance costs 645,991 645,696 Other noncurrent liabilities 480,613 485,387 Total liabilities 2,817,123 2,858,721 Equity: Amdocs Limited Shareholders' equity: Preferred Shares — Authorized 25,000 shares; 0.01 par value; 0 shares issued and outstanding — — Ordinary Shares — Authorized 700,000 shares; 0.01 par value; 288,058 and 286,330 issued and 115,917 and 117,348 outstanding, respectively 4,593 4,571 Additional paid-in capital 4,332,690 4,244,256 Treasury stock, at cost 172,141 and 168,982 ordinary shares, respectively (7,495,254 ) (7,221,313 ) Accumulated other comprehensive loss (7,390 ) (53,272 ) Retained earnings 6,709,773 6,549,517 Total Amdo